Generic Avodart

Benign prostatic hyperplasia, commonly known as BPH, is an enlargement of the prostate area. It is more rampant in older men. As men are becoming more educated about health issues, they turn to medical treatment for BPH. Dutasteride, a generic form of Avodart, has been proven as an effective treatment of BPH.

 

BPH and its symptoms that adversely affect the quality of lifestyle can be treated successfully by Dutasteride. The first indication of BPH is the frequency of need to urinate. This occurs usually at night but then progresses to the need to urine frequently throughout the day. BPH sufferers subsequently report a reduction in strength in urine stream. Discomfort accompanies this reduction. A medical doctor should conduct testing to determine if BPH is the cause of the symptoms.

 

Avodart (Dutasteride) which is produced and marketed by GlaxoSmithKline pharmaceuticals is the one and only dual 5-alpha reductase inhibitor that inhibits both type 1 and type 2 isoforms of this intracellular enzyme. Steroid 5-alpha reductase enzyme is primarily responsible for converting testosterone into a male hormone called dihydrotestosterone (DHT). BPH or prostate enlargement occurs when the levels of DHT increase in the body. Avodart stamps down DHT by more than 90 percent in two years of treatment.

Monotherapy is a symptomatic treatment of benign prostatic hyperplasia in men having enlarged prostate. It works by improving symptoms, decreasing the risk of acute retention of urine and lowering the risk of benign prostatic hyperplasia related surgery.  

Avodart along with tamsulosin is indicated for the treatment of symptomatic BPH in men with an enlarged prostate. As it is mentioned earlier, Avodart (Dutasteride) treats urinary symptoms of enlarging prostate, reduces the chances of acute urinary retention and prostate surgery. As far as dosage is concerned, Avodart can be taken in capsule form of 0.5mg each on a daily basis for monotherapy. In case of monotherapy along with alpha blocker, the daily recommended dose is Avodart 0.5mg once and Tamsulosin 0.4mg once.

Consumers in the USA are keenly awaiting the generic version of the Avodart. The sad news for them is that they will probably need to wait for five or more years before such a drug available on the market. This because GSK’s patent is set to expire in 2013 only and even then, a generic version may not be immediately available.

The best choice for consumers needing decent prostate enlargement drugs is to speak with their doctors. The latter will look into the best alternatives for you as such drugs’ effectiveness vary a lot from person to person. For some people, Avodart may work wonders, for others it may prove to be totally useless. It is therefore important to weigh the pros and cons of the drug before taking a decision.

In summary, Avodart will not have an approved generic equivalent until the year 2013. Drugs sold over the Internet that claim to be generic versions of Avodart should be treated with suspicion. They could be useless or even harmful. The best strategy for any man wanting treatment for enlarged prostate or male pattern baldness is a frank and honest discussion with a medical professional, so that a treatment’s safety and effectiveness can be adequately monitored.